Nephrin expression is reduced in human diabetic nephropathy: Evidence for a distinct role for glycated albumin and angiotensin II

Diabetes

Volumn 52, Issue 4, 2003, Pages 1023-1030

  Doublier, Sophie ^a   Salvidio, Gennaro ^b   Lupia, Enrico ^a   Ruotsalainen, Vesa ^c   Verzola, Daniela ^b   Deferrari, Giacomo ^b   Camussi, Giovanni ^a,d  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF OULU   (Finland)

^d MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANGIOTENSIN; GLYCOSYLATED ALBUMIN;

ADULT; AGED; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOSKELETON; DIABETIC NEPHROPATHY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY BIOPSY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS;

ADULT; AGED; ALBUMINURIA; ANGIOTENSIN II; BIOPSY; BLOTTING, WESTERN; CELLS, CULTURED; CYTOCHALASIN B; CYTOSKELETON; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION; HUMANS; KIDNEY; MALE; MEMBRANE PROTEINS; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; NEPHROTIC SYNDROME; PROTEINS; RECEPTORS, IMMUNOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERUM ALBUMIN; TISSUE DISTRIBUTION;

EID: 0345505674     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.4.1023     Document Type: Article

References (48)

1. Estacio RO, Schrier RW: Diabetic nephropathy: pathogenesis, diagnosis, and prevention of progression. Adv Intern Med 46:359- 408, 2001
2. Barnas U, Mayer G: Glomerular proteinuria in renal transplant patients: mechanisms and treatment. Kidney Int Suppl 63:S78-S80, 1997
3. Remuzzi G, Ruggenenti P: Prognosis of diabetic nephropathy: how to improve the outcome. Diabetes Res Clin Pract 39:S49-S53, 1998
4. Narita T, Koshimura J, Suzuki K, Murata M, Meguro H, Fujita H, Kitazato H, Ito S: Effects of short-term glycemic control, low protein diet and administration of enalapril on renal hemodynamics and protein permselectivity in type 2 diabetic patients with microalbuminuria. Tohoku J Exp Med 189:117-133, 1999
5. Lemley KV, Blouch K, Abdullah I, Boothroyd DB, Bennett PH, Myers BD, Nelson RG: Glomerular permselectivity at the onset of nephropathy in type 2 diabetes mellitus. J Am Soc Nephrol 11:2095-2105, 2000
6. Tryggvason K, Wartiovaara J: Molecular basis of glomerular permselectivity. Curr Opin Nephrol Hypertens 10:543-549, 2001
7. Kestila M, Lenkkeri U, Manrukko M, Lamerdin J, McCready P, Putaala H, Ruotsalainen V, Morita. T, Nissinen M, Herva R, Kashtan CE, Peltonen L, Holmberg C, Olsen A, Tryggvason K: Positionally cloned gene for a novel glomerular protein - nephrin - is mutated in congenital nephrotic syndrome. Mol Cell 1:575-582, 1998
8. Lenkkeri U, Mannikko M, McCready P, Lamerdin J, Gribouval O, Niaudet PM, Antignac CK, Kashtan CE, Homberg C, Olsen A, Kestila M, Tryggvason K: Structure of the gene for congenital nephrotic syndrome of the Finnish type (NPHS1) and characterization of mutations. Am J Hum Genet 64:51-61, 1999
9. Topham PS, Kawachi H, Haydar SA, Chugh S, Addona TA, Charron KB, Holzman LB, Shia M, Shimizu F, Salant DJ: Nephritogenic mAb 5-1-6 is directed at the extracellular domain of rat nephrin. J Clin Invest 104:1559-1566, 1999
10. Kawachi H, Koike H, Kurihara H, Yaoita E, Orikasa M, Shia MA, Sakai T, Yamamoto T, Salant DJ, Shimizu F: Cloning of rat nephrin: expression in developing glomeruli and in proteinuric states. Kidney Int 57:1949-1961, 2000
11. Luimula P, Ahola H, Wang SX, Solin ML, Aaltonen P, Tikkanen I, Kerjaschki D, Holthofer H: Nephrin in experimental glomerular disease. Kidney Int 58:1461-1468, 2000
12. Furness PN, Hall LL, Shaw JA, Pringle JH: Glomerular expression of nephrin is decreased in acquired human nephrotic syndrome. Nephrol Dial Transplant 14:1234-1237, 1999
13. Doublier S, Ruotsalainen V, Salvidio G, Lupia E, Biancone L, Conaldi PG, Reponen P, Tryggvason K, Camussi G: Nephrin redistribution on podocytes is a potential mechanism for proteinuria in patients with primary acquired nephrotic syndrome. Am J Pathol 158:1723-1731, 2001
14. Huh W, Kim DJ, Kim MK, Kim YG, Oh HY, Ruotsalainen V, Tryggvason K: Expression of nephrin in acquired human glomerular disease. Nephrol Dial Transplant 17:478-484, 2002.
15. Aaltonen P, Luimula P, Åström E, Palmen T, Grönholm T, Palojoki E, Jaakkola I, Ahola H, Tikkanen I, Holthöfer H: Changes in the expression of nephrin gene and protein in experimental diabetic nephropathy. Lab Invest 81:1185-1190, 2001
16. Forbes JM, Bonnet F, Russo LM, Burns WC, Cao Z, Candido R, Kawachi H, Allen TJ, Cooper ME, Jerums G, Osicka TM: Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria. J Hypertes 20:985-992, 2002
17. Oldfield MD, Bach LA, Forbes JM, Nikolic-Paterson D, McRobert A, Thallas V, Atkins RC, Osicka T, Jerums G, Cooper ME: Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest 108:1853-1863, 2001
18. Rossing P, Astrup AS, Smidt UM, Parving HH: Monitoring kidney function in diabetic nephropathy. Diabetologia 37:708-712, 1994
19. Conaldi PG, Biancone L, Bottelli A, De Martino A, Camussi G, Toniolo A: Distinct pathogenic effects of group B coxsackieviruses on human glomerular and tubular kidney cells. J Virol 71:9180-9187, 1997
20. Striker GE, Striker LJ: Glomerular cell culture. Lab Invest 53:122-131, 1985
21. Moutabarrik A, Nakanishi I, Zaid D, Namiki M, Kawaguchi N, Onishi S, Ishibashi M, Okuyama A: Interleukin-1-beta activation of cultured glomerular epithelial cells. Exp Nephrol 2:196-204, 1994
22. Delarue F, Virone A, Hagege J, Lacave R, Peraldi M-N, Adida C, Rondeau E, Feunteun J, Sraer J-D: Stable cell line of T-SV40 immortalized human glomerular visceral epithelial cells. Kidney Int 40:906-912, 1991
23. Coers W, Huitema S, van der Horst MLC, Weening JJ: Puromycin aminonucleoside and adriamycin disturb cytoskeletal and extracellular matrix protein organization but not protein synthesis of cultured glomerular epithelial cells. Exp Nephrol 2:40-50, 1994
24. Conaldi PG, Biancone L, Bottelli A, Wade-Evans, Racusen LC, Orlandi V, Serra C, Camussi G, Toniolo A: HIV-1 kills renal tubular cells by a mechanism that involves fas and caspase-3 activation. J Clin Invest 102:2041-2049, 1998
25. Cohen MP, Ziyadeh FN, Lautenslager GT, Cohen JA, Shearman CW.; Glycated albumin stimulation of PKC-β activity is linked to increased collagen IV in mesangial cells, Am J Physiol 276:F684-F690, 1999
26. Cohen MP: Diabetes and Protein Glycation. Clinical and Pathophysiologic Relevance. Philadeiphia, PA, JC Press, 1996
27. Cohen MP, Hud E: Measurement of plasma glycoalbumin levels with a monoclonal antibody-based ELISA. J Immunol Methods 122:279-283, 1989
28. Camussi G, Brentjens JR, Noble B, Kerjaschki D, Malavasi F, Roholt OA, Farquhar MG, Andres G: Antibody-induced redistribution of Heymann antigen on the surface of cultured glomerular visceral epithelial cells: possible role in the pathogenesis of Heymann glomerulonephritis. J Immunol 135:2409-2416, 1985
29. Wessells NK, Spooner BS, Ash JF, Bradley MO, Luduena MA, Taylor EL, Wrenn JT, Yamaa K: Microfilaments in cellular and developmental processes. Science 171:135-143, 1971
30. Tryggvason K: Unraveling the mechanisms of glomerular ultrafiltration: nephrin, a key component of the slit diaphragm. J Am Soc Nephrol 10:2440-2445, 1999
31. Yuan H, Takeuchi E, Salant DJ: Podocyte slit-diaphragm protein nephrin is linked to the actin cytoskeleton. Am J Physiol Renal Physiol 282:F585-F591, 2002
32. Yuan H, Takeuchi E, Taylor G, McLaughlin M, Brown D, Salant DJ: Nephrin dissociates from actin, and its expression is reduced in early experimental membranous nephropathy. J Am Soc Nephrol 13:946-956, 2002
33. Bjorn SF, Bangstad HJ, Hanssen KF, Nyberg G, Walker JD, Viberti GC, Osterby R: Glomerular epithelial foot processes and filtration slits in IDDM patients. Diabetologia 38:1197-1204, 1995
34. Raptis AE, Viberti G: Pathogenesis of diabetic nephropathy. Exp Clin Endocrinal Diabetes 109:S424-S437, 2001
35. Cooper ME: Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy. Diabetologia 44:1957-1972, 2001
36. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
37. Mulec H, Blohmè G, Grande B, Bjorck S: The effect of metabolic control on rate of decline in renal function in insulin-dependent diabetes mellitus with overt diabetic nephropathy. Nephrol Dial Transplant 13:651-655, 1998
38. Raj DSC, Choudhury D, Welbourne TC, Levi M: Advanced glycation end products: a nephrologist's perspective. Am J Kidney Dis 35:365-380, 2000
39. Chen S, Cohen MP, Ziyadeh FN: Amadori-glycated albumin in diabetic nephropathy: pathological connections. Kidney Int 58:S40-S44, 2000
40. Singh R, Barden A, Mori T, Beilin L: Advanced glycation end-products: a review. Diabetologia 44:129-146, 2001
41. Warnock DG: Prevention, protection, and the intrarenal rennin-angiotensin systems. Semin Nephrol 21:593-602, 2001
42. Praga M: Slowing the progression of the renal failure. Kidney Int 61:18-22, 2002
43. Schmidt AM, Stern D: RAGE: a new target for the prevention and treatment of the vascular and inflammatory complications of diabetes. Trends Endocrinol Metab 11:368-375, 2000
44. Goova MT, Li J, Kislinger T, Qu W, Lu Y, Bucciarelli LG, Nowygrod S, Wolf BM, Caliste X, Yan SF, Stem D, Schmidt AM: Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol 159:399-403, 2001
45. Tanji N, Markowitz GS, Fu C, Kislinger T, Taguchi A, Pischetsrieder M, Stern D, Schmidt AM, D'Agati VD: Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease. J Am Soc Nephrol 11:1656-1666, 2000
46. Bonnet F, Cooper ME, Kawachi H, Allen TJ, Boner G, Cao Z: Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension. Diabetologia 44:874-877, 2001
47. Benigni A, Tomasoni S, Gagliardini E, Zoja C, Grunkemeyer J, Kalluri R, Remuzzi G: Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis. J Am Soc Nephrol 12:941-948, 2001
48. Kelly DJ, Aaltonen P, Cox AJ, Rumble JR, Langham R, Panagiotopoulos S, Jerums G, Holthbfer H, Gilbert RE: Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of anti-proteinuric therapies. Nephrol Dial Transplant 17:1327-1332, 2002